© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

International issuers crowd into Swiss francs

Foreign corporate issuance running at record high
AI issuance is becoming increasingly concentrated — beware

ING banker moves to Asian Development Bank

Recently departed banker to resurface in Asia

Csquare's IPO to chip away at $3bn of ABS debt

IPO documents reveal data center portfolio purchase
AI issuance is becoming increasingly concentrated — beware
Sub-sections
  • Jacobio Pharmaceuticals is preparing to launch the roadshow for its Hong Kong IPO after winning approval to list from the city’ stock exchange last week.
  • China's Harbour Biomed, a clinical-stage biopharmaceutical company, has hit the road for its up to HK$1.8bn ($230.4m) listing.
  • Having entered default on Thursday, November 26 as the 30-day grace period on a missed coupon payment expired, Suriname has improved the terms on a consent solicitation that — if accepted by at least three quarters of bondholders — would allow it to escape the default and buy time for a more comprehensive debt restructuring.